Chen-Xiong Hsu

7PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Mar 22, 2025
Chemoradiotherapy Combined With Modulated Electro-Hyperthermia (mEHT) Converts Initially Inoperable Esophageal Cancer to Operable Disease.

Deng-Yu Kuo, Pei-Wei Shueng, Shan-Ying Wang

|Aug 09, 2023
Integrating subvolume dose and myocardial perfusion imaging parameters to assess the impact of radiation therapy on heart function in breast cancer patients: A comparative analysis between left- and right-sided breast cancer.

Shan-Ying Wang, Wei-Ta Tsai, Kuan-Heng Lin

|Nov 30, 2022
Addition of metformin to non-small-cell lung cancer patients with or without diabetes.

Hua-Fen Chen, Rong Lin, Chen-Xiong Hsu

|Nov 15, 2022
Factors affecting long-term survival of non-small-cell lung cancer patients with concomitant type 2 diabetes mellitus.

Ju-Ying Jiang, Chen-Xiong Hsu, Sang-Hue Yen

|Nov 09, 2022
Combined modality therapy for patients with esophageal squamous cell carcinoma: Radiation dose and survival analyses.

Pei-Wei Shueng, Chun-Chieh Huang, Yu-Ming Liu

|Oct 26, 2022
Comments on "dynamic 18 F-FDG PET/CT can predict the major pathological response to neoadjuvant immunotherapy in non-small cell lung cancer".

Shan-Ying Wang, Yu-Chien Shiau, Chen-Xiong Hsu

Pageof 2

Frequent Collaborators

2 joint publications

Pei-Wei Shueng

1 joint publications

Tung-Hsin Wu